Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells

Journal of Clinical Investigation

Volumn 104, Issue 7, 1999, Pages 865-874

  Baldassarre, Gustavo ^a   Belletti, Barbara ^a   Bruni, Paola ^a   Boccia, Angelo ^a   Trapasso, Francesco ^b,c   Pentimalli, Francesca ^a   Barone, Maria Victoria ^a   Chiappetta, Gennaro ^a   Vento, Maria Teresa ^a   Spiezia, Stefania ^a   Fusco, Alfredo ^b,c   Viglietto, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^c Univ Studi di Cantanzaro   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLINE; ISOENZYME; MUTANT PROTEIN; PROTEIN P27;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; THYROID CARCINOMA;

EID: 0032696891     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6443     Document Type: Article

References (36)

1. Hedinger, C., Williams, E.D., and Sobin, L.H. 1989. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer, 63:908-911.
2. Fearon, E.R., and Vogelstein, B. 1990. A genetic model for colorectal tumorigenesis. Cell. 61:759-767.
3. Wynford-Thomas, D. 1993. Molecular basis of epithelial tumorigenesis: the thyroid model. Crit. Rev. Oncog. 4:1-23.
4. Grieco, M., et al. 1990. PTC is a novel rearranged form of the ret protooncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 60:557-563.
5. Namba, H., Rubin, S.A., and Fagin, J.A. 1990. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol. Endocrinol. 4:1474-1479.
6. Fagin, J.A., et al. 1993. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas J. Clin. Invest. 91:179-184.
7. Sherr, C.J. 1994. G1 phase progression: cycling on cue. Cell, 79:551-555.
8. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323-330.
9. Sherr, C.J. 1993. Mammalian G1 cyclins. Cell. 73:1059-1065.
10. Sherr, C.J., and Roberts, J.M. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
11. el-Deiry, W.S., et al. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:817-825.
12. Polyak, K., Lee, M., Koff, A., Roberts, J.M., and Massaguè, J. 1994. Cloning of p27kip-1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell. 78:59-66.
13. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639-649.
14. Nakayama, K., et al. 1996. Mice lacking p27(kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:707-721.
15. Catzavelos, C., et al. 1997. Decreased levels of the cell-cycle inhibitor p27kip1 protein: prognostic implications in primary breast cancer. Nat. Med. 3:227-230.
16. Loda, M., et al. 1997. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas, Nat. Med. 3:231-234.
17. Esposito, V., et al. 1997. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 57:3381-3385.
18. Erickson, L.A., et al. 1998. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod. Pathol. 11:169-174.
19. Resnick, M.B., Schacter, P., Finkelstein, Y., Kellner, Y., and Cohen, O. 1998. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Mod. Pathol. 11:735-739.
20. Yaroslavskiy, B., Watkins, S., Donnemberg, A.D., Patton T.J., and Steinman, R.A. 1999. Subcellular and cell-cycle expression profiles of Cdk inhibitors in normal differentiating myeloid cells. Blood. 93:2907-2917.
21. Battista, S., et al. 1998. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene. 17:377-385.
22. Pagano, M., et al. 1993. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol. 121:101-111.
23. Baldassarre, G, et al. 1999. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Oncogene. In press.
24. Motokura, T., Keyomarsi, K., Kronenberg, H.M., and Arnold, A. 1992. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J. Biol. Chem. 267:20412-20415.
25. KIP1 in multistage colorectal carcinogenesis. Cancer Res. 58:114-122.
26. Singh, S.P.J., et al. 1998. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 58:1730-1735.
27. Depoortere, F., et al. 1998. A requirement for cyclin D3-cylin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J. Cell Biol. 140:1427-1439.
28. Font de Mora, J., Uren, A., Heidaran, M., and Santos, E. 1997. Biological activity of p27 and its amino- and carboxy-terminal domains in G2/M transition of Xenopus oocytes. Oncogene. 15:2541-2551.
29. Sheaff, R., Groudine, M., Gordon, M., Roberts, J.M., and Clurman, B.E. Cyclin E-Cdk2 is a regulator of p27, 1997. Genes Dev. 11:1464-1478.
30. Van den Heuvel, S., and Harlow, E. Distinct role of cyclin-dependent kinases in cell cycle control, 1993. Science. 262:2050-2053.
31. Orend, G., Hunter, T., and Ruoslahti, E. 1998. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene. 16:2575-2583.
32. La Baer, J., et al. 1997. New functional activities for the p21 family of Cdk inhibitors. Genes Dev. 11:847-862.
33. Reynisdottir, I., and Massagué, J. 1997. The subcellular locations of p15 and p27 coordinate their inhibitory interactions with Cdk4 and Cdk2. Genes Dev: 11:492-503.
34. Pines, J., and Hunter, T. 1994. The differencial localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J. 13:3772-3781.
35. Vlach, J., Hennecke, S., Aleviozopoulos, K., and Amati, B. 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27 is abrogated by c-Myc. EMBO J. 15:6595-6604.
36. Dickens, M., et al. 1997. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science. 277:693-696.